Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fanti Stefano, Turco Fabio, Tombal Bertrand, Walz Jochen, Hofman Michael S, Hadaschik Boris, Emmett Louise, Tilki Derya, Pecoraro Giovanna, Salfi Giuseppe, Attard Gerhardt, Beltran Himisha, Bjartell Anders, Briganti Alberto, Burger Irene A, Castro Elena, Cerci Juliano J, Chiti Arturo, Cooperberg Matthew, Fizazi Karim, Fossati Nicola, Gafita Andrei, Gallina Andrea, Goffin Karolien, Horvath Lisa G, Hugosson Jonas, Iagaru Andrei, James Nicholas D, Kasivisvanathan Veeru, Koh Dow-Mu, Kristiansen Glen, Kumar Rakesh, Lecouvet Frederic, Loeb Stacy, McKay Rana R, Morris Michael J, Murphy Declan G, Murthy Vedang, Naoun Natacha, Oprea-Lager Daniela E, Ost Piet, O'Sullivan Joe, Padhani Anwar R, Palapattu Ganesh, Paone Gaetano, Petralia Giuseppe, Roobol Monique J, Sartor Oliver A, Sathekge Mike, Schuster David M, Seibert Tyler M, Spratt Daniel E, Tempany Clare, Tunariu Nina, Vargas H Alberto, Vogl Ursula M, Wyatt Alexander W, Zilli Thomas, Lin Hui-Ming, Omlin Aurelius, Gillessen Silke, Herrmann Ken
Аннотация
OUTCOMES MEASUREMENTS AND STATISTICAL ANALYSIS: Consensus was only reached on 17 of 88 questions (19%), of which six (7%) received a strong consensus. Specifically, consensus was reached for two of 17 questions (14%) in "how to diagnose PC"; seven of 16 (44%) in "how to stage PC"; three of 14 (21%) in "Biochemical Recurrence Scenario"; two of 11 (18%) in "metastatic disease: what to do?"; zero of 18 (0%) in "monitoring metastatic PC"; and three of 12 (25%) in "radioligand therapy and imaging."
CONCLUSIONS: The voting results and their discussion may assist physicians in navigating controversial areas of clinical management related to diagnosis, staging, and restaging in the different clinical settings for PC, particularly where high-level evidence is scarce or conflicting. The findings can also help funders and policymakers in prioritising areas for future research.